drugset / Trial / NCT07314346
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Non-randomizedSequentialOpen-labelTreatment
Summary
Drug-drug interaction study between Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Timeline
- Start
- 2025-01-07
- Primary completion
- 2026-08
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bemnifosbuvir/Ruzasvir | Unknown | 180 mg | Oral |
| Subject | Bemnifosbuvir/Ruzasvir | Unknown | 550 mg | Oral |
| Subject | Buprenorphine/Naloxone | Unknown | 6 mg | — |
| Subject | Buprenorphine/Naloxone | Unknown | 24 mg | — |
| Subject | Methadone | Other / unclassified | — | — |
Indications
No indication recorded.